FindTrial
Sign In

Diagnostic significance of high sensitivity C reactive protein and procalcitonin on patients with diabetic foot osteomyelitis

Diagnostic significance of high sensitivity C reactive protein and procalcitonin on patients with diabetic foot osteomyelitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DCD-15006150
Enrollment
Unknown
Registered
2015-03-23
Start date
2015-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot osteomyelitis

Interventions

Gold Standard:
Index test:

Sponsors

Tianjin Medical University Metabolic Diseases Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age older than 18 years old; 2. patients with DFO, the location of DFO is not limited; (The diagnosis of DFO based on recommended diagnosis consensus by international diabetic foot working group); 3. Patients agreed to join the study and signe informed consent.

Exclusion criteria

Exclusion criteria: 1. DFO patients with severe lower limb ischemia (ABI 98 umol / L, women> 106umol/L); 7. liver insufficiency (ALT>100IU/L); 8. Cardiac function 4 level (NYHA); 9. Patients can not understand the research programs and do not want to participate in.

Design outcomes

Primary

MeasureTime frame
PCT;CRP;bone microbial culture;bone pathology;—

Secondary

MeasureTime frame
foot X ray plain;baseline data;Biochemical indicators;—

Countries

China

Contacts

Public ContactPenghua Wang
wph200000@163.com+86 022-23333208

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026